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Warfarin, phenytoin and thyroid hormones - 
a binding combination? 
Etv &If3 Tern 
The patient is a 72-year-old female resident of a nursing The medical notes at the facility are sparse, and are 
home. Her past medical history consists of osteoarthritis, summarised below. 
type 2 diabetes mellitus. epilepsy and hyperthym~dism. In 
addition, she has had valvular heart disease, with a heart 
valve replacement in 1999. 
Her current medications are: 
Carbimazole lOrng daily 
Phenytoin 300rng daily [was 400rng until 10 days before 
review, and was 300mg approximatsly a month ago; see 
labo ia t0~ tests1 
The lady has a moderate degree of cognitwe impairment 
Warfarin 3mg daily (was 4mg daily until I 0  days ago) and requires the assistance of two people for her activities 
Ranitidine 150mg twice-daily of daily living. The nurses arranged for the doctor to see 
her three days before your review, indicating that she was Recently ceased - Owontin 5mg twice daily. ceased 3 
refusing her analgesics as she said: have no pain and days before rev~ew). need the tablets'. Her blood Dressure and heart rate were 
Date of.entry 
1 month ago 
8 days ago 
3 days ago 
I .A number of laboratory tests are available in the notes at the normal and the nurses indicatethat, other than the fluctuating facility. These are shown below: mild confusion. she is reasonably easy to manage and stable. 
> 
Commants 
Dilantin low, increase to 2bd 
Note TFTs, Leave as T3fl4 normal 
Oilantin high, raduca to 3aDmg daily. INR 
high. rsduce warfarin to 3mg daily 
Very mnfused, no evidence of pain - 
cease0xycontin. Repeat bloods 
Clinical assessment 
This is an interesting case of changes made to medications as 
a result of interpretation of laboratory tests. The tests from 
one month previously ~nd~cated a low phenytoin level and also 
a low TSH. At that timethe medical practitioner increased the 
dose of phenytoin to 400mg (from 300mg daily) and did not 
change ths carbimazole dose as the T3 and T4 were normal. 
Phenytoia.dose changes 
As all pharmacists would know, a change in phenytoin dose of 
this magnitude is inappropriate and may result in an excessive 
increase in levels. as later occurs i n  this patient. This 
problem would need to be addressed with some explanation. 
especially, as when the level was later elevated, the doctor 
reduced the dose by lOOmg to 300mg. Advice on this aspect 
of this case can be found in a previous medication review 
article addressing this issue.' 
This patient is also taking warfarin, and the likely competition 
between this and the phenytoin would increase the free 
fraction of both drugs. It is interesting to consider the-free 
fraction of the phenytoinrelated m the level taken one month 
ago, as it may well have been therapeutic. A serum albumin 
level would assist in the interpretation of this low phenytoin 
level. Depending on the clinical situation (for example 
the frequency of any seizures or the presence of any toxic 
symptoms) the dose increase in phenytoin may not have been 
necessary. 
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Interpretation of thyroid function tests 
Ihe thyroid ,function tests, however, require further 
discussion. As the doctor correctly pointed out, this lady's 
thyroxine (T4) and tri-iodothyroxine (T3) levels were normal. 
despitea thyroid stimulating hormone (TSHI level which was 
significantly inhibited, consistent with hyperthyroidism. 
Thyroxine is highly bound (over 99%) to thyroid binding 
globulin and may be displaced from this protein by other highly 
protein bound drugs? In this case. the presence of phenytoin 
and warfarin (both highly protein bound) may increase the 
free thyroxine and this would result in an increased uptake 
of thyroxine in the tissues, resulting in a reduced total serum 
level. Thus the use of highly protein bound drugs increases 
the 'free fraction' of both of the thyroid hormones, such 
that normal levels may be consistent with excessive thyroid 
hormone effects. This concept is shown in Figure 1. 
Figure 1 Concept of increased free fraction 
As can be seen from the concept outlined in Figure 1. a 
total level of 91 units (in situation C) would be biologically 
equivalent, in terms of free amount, to a total level of 
approximately 100 in situation A. In this case scenario, levels 
of thyroxine and T3 were normal, but could have provided a 
biologically increased free amount which was then responded 
to by a decrease in TSH. Thus. the patient'sTSH provided the 
more appropriate or'true' interprethon of the thyroid status. 
and hyperthyroidism should be suspected. 
While there were no overt signs or symptoms of 
hyperthyroidism [the heart rate was only slightly elevated and 
the weight was stable), i t  is interesting to note the change in 
the patient's INR. There are two possibilities that may explain 
this increase in INR. Firstly, the increase in the phenytoin 
dosage may have' increased.the competition between the 
warfarin and phen$oin and resulted in a transient increase in 
free warfarin and therefore its effects. In contrast to this, the 
increased dose of phenytoin could induce the metabolism of 
warfarin and may result in a decreased warfarin effect. 
- have resulted in an increased competition with thyroxine and 
T3 for thyroid binding globulin, resulting in an ~ncreased free 
level and a resultant hyperthyroid (at least biochemically) 
status. Hyperthyroidism could. In turn, have increased the 
catabolism of liver-synthesised clotting factors. increasing the 
sensitivity to warfarin. 
Thus. in this case scenario, there is sufficient reason to 
suspect that the JSH levels obtained are representative of the 
true thyroid status, and some consideration of an increase in 
the dose of carbimazole should be undertaken. In addition, the 
significant changes in phenytoin dose may have contributed 
to changes In warfarin effects and thyroid status. in turn 
modifying the phenyto~n free levels. 
Actions and recommendations 
It would be appropriate to discuss with the medical 
practitioner the possibility that this patient has -a degree 
of hyperthyroidism, and also to outline appropriate dose 
modification of phenytoin and the potential impact of the 
multiple protein binding issues in the case. It would be useful 
to determine the current serum albumin, and also the current 
thyroxine and T3 levels. A Free Thyroxine Index and Thyroid 
BindingGlobulin test may also assist with interpretation of - 
the current thyroid status. As blood tests were ordered three 
days ago, some of these parameters may be available when 
the discussion with the doctor takes place. 
It is important in this case (as in all cases) to consider the 
patient's current clinical status. The resident is described 
as relatively stable, and although the 'numbers' are a little 
abnormal, changes in medication should be undertaken with 
care. 
In summaryrThe onecircular, ring-like. relationship between 
the thyroid hormones, phenytoin and warfarin lead to a 
complex situation which does not clearly follow the rules and 
where aspects of them a l l  are important. Interpretation of 
the case should take into account the patient's clinical and 
symptomatic situation which could assist in overcoming the 
dnrkness in which the binding issues have placed them. 
(Ed. Apologiss to JRR Tolkien.) 
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